Viz RV/LV vs AVIEW Lung Nodule CAD
AI Verdict
Choose Viz RV/LV if…
Choose Viz RV/LV if your primary need is rapid, AI-driven risk stratification for suspected pulmonary embolism. This tool excels at automating crucial RV/LV ratio measurements from CTPA scans, enabling quick identification of high-risk patients and facilitating immediate, coordinated care team response through its integrated communication platform.
View Viz RV/LV →Choose AVIEW Lung Nodule CAD if…
Choose AVIEW Lung Nodule CAD if your focus is on comprehensive lung cancer screening, long-term nodule management, and broader pulmonary/cardiovascular health assessment. This solution provides detailed nodule detection, classification, 3D quantification, and Lung-RADS reporting, alongside simultaneous analysis for emphysema and coronary artery calcification, making it ideal for robust screening programs and follow-up protocols.
View AVIEW Lung Nodule CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz RV/LV | AVIEW Lung Nodule CAD |
|---|---|---|
| Deployment | Cloud-based | On-premises and cloud environment |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV emphasizes rapid, mobile-first alerts and a HIPAA-compliant communication platform for immediate care coordination, which is crucial for acute conditions. The inclusion of 'Viz Assist' with generative AI further streamlines workflows by providing real-time insights and recommendations, enhancing overall user experience for urgent scenarios.
Clinical Value
AVIEW Lung Nodule CADAVIEW Lung Nodule CAD offers comprehensive screening for lung cancer, COPD, and coronary artery calcification from a single CT scan, providing broad diagnostic utility across multiple significant diseases. Its high sensitivity for nodule detection and adoption in national screening programs, coupled with reported reductions in reading time, demonstrate substantial and wide-ranging clinical impact.
Pricing & Value
AVIEW Lung Nodule CADWhile neither tool publicly discloses pricing, AVIEW Lung Nodule CAD explicitly highlights 'cost-saving potential' and a '70% reduction in reading time,' offering a clear and quantifiable value proposition through increased efficiency for radiology departments. This direct articulation of cost benefits provides a stronger indication of value for potential users.
Enterprise Readiness
AVIEW Lung Nodule CADAVIEW Lung Nodule CAD offers superior deployment flexibility, supporting cloud-based, hybrid, local on dedicated hardware, and locally virtualized solutions (VM, Docker). This versatility allows healthcare enterprises to integrate the tool into diverse IT infrastructures and adhere to specific data residency or security policies more effectively.
Innovation
AVIEW Lung Nodule CADAVIEW Lung Nodule CAD demonstrates higher innovation through its 'Big 3' simultaneous analysis of lung nodules, emphysema, and coronary artery calcification from a single low-dose CT scan. This integrated, multi-modal approach provides a more holistic and comprehensive diagnostic insight compared to Tool A's focused measurement for a single acute condition.
Support & Docs
Viz RV/LVViz.ai provides a robust and clearly defined support structure, including a dedicated customer success team with clinical and workflow specialists, customer success managers, and clinical research scientists. They also offer a comprehensive Knowledge Base and a Trust Center with detailed security and privacy documentation, indicating a strong commitment to customer assistance and transparency.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz RV/LV | AVIEW Lung Nodule CAD |
|---|---|---|
| Name | Viz RV/LV | AVIEW Lung Nodule CAD |
| Company | Viz.ai | Coreline Soft Co. |
| Description | Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. | AVIEW Lung Nodule CAD is an AI-powered software by Coreline Soft Co. that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification. |
| Primary Function | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement from CTPA scans for pulmonary embolism risk stratification. | AI-based pulmonary nodule detection and analysis on chest CT scans, including classification, 3D quantification, and Lung-RADS reporting. |
| Additional Capabilities | Seamless component of the Viz PE Solution for suspected pulmonary embolism detection, AI-powered alerts and notifications, high-fidelity mobile DICOM image viewer, HIPAA-compliant communication platform. | Nodule matching and volume doubling time (VDT) calculation, simultaneous analysis of lung nodules, emphysema, and coronary artery calcification (Big 3), quantitative emphysema analysis, Coronary Artery Calcification (CAC) scoring. |
| Specialties | Emergency Medicine, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Viz RV/LV and AVIEW Lung Nodule CAD.